SUPERNUS PHARMACEUTICALS, INC.

SUPN

SUPERNUS PHARMACEUTICALS, INC.

SUPN

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-03-18Shares Purchased (TTM):0Shares Sold (TTM):374,191

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:55,739,419Shares Outstanding:57,647,548Institutional Ownership Pct.:96.69%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	180	185	128	151	145	116	69	32	52	63	95
Debt Securities Available For Sale Excluding Accru…	192	199	180	130	378	348	384	372	295	234	105
Accounts Receivable Net Current	212	182	188	171	141	146	142	145	152	148	142
Inventory Net	-	-	112	-	44	49	54	64	68	75	83
Prepaid Expense And Other Assets Current	56	78	65	62	31	29	36	27	23	24	24
Assets Current	723	732	644	594	739	688	686	640	591	544	449
Debt Securities Available For Sale Excluding Accru…	-	-	-	-	-	-	0	0	0	12	25
Restricted Cash Noncurrent	1	1	1	1	0	0	0	0	-	-	-
Property Plant And Equipment Net	10	10	11	11	11	11	12	12	12	13	14
Intangible Assets Net Excluding Goodwill	469	550	569	623	481	502	522	540	560	580	641
Goodwill	119	121	125	119	117	117	117	117	117	117	117
Deferred Income Tax Assets Net	49	31	38	9	6	-	0	-	-	-	-
Other Assets Noncurrent	55	56	64	62	28	29	32	34	36	38	39
Assets	1,428	1,501	1,453	1,420	1,382	1,347	1,368	1,343	1,316	1,304	1,285
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	108	101	108	109	78	77	76	76	83	86	78
Convertible Notes Payable Current	-	-	-	-	-	-	-	-	-	-	0
Business Combination Contingent Consideration Liab…	0	0	31	11	0	30	47	47	47	51	46
Other Liabilities Current	40	83	38	26	28	5	0	0	4	10	1
Liabilities Current	347	374	338	331	286	282	292	292	309	315	288
Business Combination Contingent Consideration Liab…	0	0	0	0	-	-	0	0	1	1	8
Operating Lease Liability Noncurrent	29	30	30	31	24	26	27	29	30	33	34
Deferred Income Tax Liabilities Net	-	-	0	0	0	1	5	7	11	20	35
Other Liabilities Noncurrent	20	20	22	8	8	7	8	7	7	7	9
Liabilities	397	424	391	370	319	317	332	336	358	375	373
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	574	561	544	528	497	486	479	466	455	447	432
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	0	-0	-1	-1
Retained Earnings Accumulated Deficit	457	516	518	522	567	545	556	541	503	483	481
Stockholders Equity	1,031	1,077	1,062	1,050	1,064	1,031	1,036	1,007	957	929	912
Liabilities And Stockholders Equity	1,428	1,501	1,453	1,420	1,382	1,347	1,368	1,343	1,316	1,304	1,285
Stockholders Equity
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	130	130	130	130	130	130	130	130	130	130	130
Common Stock Shares Issued	58	58	57	57	56	56	56	55	55	55	55
Shares Outstanding	58	58	57	57	56	56	56	55	55	55	54

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-6.12%	-4.78%	-6.08%	-	-	-	-	-	-	-	-	-
2025	-2.25%	-3.92%	3.55%	20.22%	25.31%	40.77%	-3.55%	9.10%	2.07%	-10.11%	-9.68%	-12.49%
2024	-13.35%	-14.54%	-1.76%	26.11%	10.29%	21.70%	5.39%	7.15%	11.10%	-2.01%	-6.25%	1.89%
2023	-	-	-	-1.28%	-16.23%	-28.41%	17.26%	23.04%	22.11%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-09-30
Liquidity Ratios
Current Ratio	2.08	1.96	1.90	1.80	2.58	2.44	2.35	2.20	1.91	1.73	1.56
Quick Ratio	1.92	1.75	1.38	1.61	2.32	2.16	2.04	1.88	1.62	1.42	1.19
Working Capital	376.12M	357.65M	306.01M	263.26M	452.51M	405.81M	393.67M	348.50M	282.35M	229.77M	161.83M
Leverage & Debt
Debt to Equity	0.38	0.39	0.37	0.35	0.30	0.31	0.32	0.33	0.37	0.40	0.41
Interest Coverage TTM	-	-	-	-	-	-	-	-	10.95	-3.07	12.45
Debt Ratio	0.28	0.28	0.27	0.26	0.23	0.23	0.24	0.25	0.27	0.29	0.29
Efficiency & Turnover
Asset Turnover TTM	0.59	0.55	0.51	0.49	0.49	0.50	0.50	0.49	0.39	0.39	0.41
Days Sales Outstanding TTM	77.46	77.01	83.74	84.79	80.48	80.15	78.27	80.21	89.84	97.41	91.42
Receivables Turnover TTM	4.71	4.74	4.36	4.30	4.54	4.55	4.66	4.55	4.06	3.75	3.99
Per Share Metrics
Diluted EPS TTM	-1.89	-0.50	-0.68	-0.34	1.14	1.11	1.32	0.76	0.06	0.00	0.47
Free Cash Flow Per Share TTM	0.32	1.43	0.81	1.25	3.32	2.92	3.11	2.95	1.64	1.89	1.70
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	88.07%	89.42%	89.63%	88.61%	88.53%	88.42%	88.23%	88.87%	87.54%	86.29%	85.73%
Operating Profit Margin TTM	-15.71%	-7.77%	-8.66%	-5.42%	9.64%	11.16%	12.34%	10.66%	1.66%	-1.27%	4.92%
Net Profit Margin TTM	-13.23%	-3.74%	-5.36%	-2.80%	9.70%	9.27%	11.16%	6.63%	0.54%	0.05%	4.20%
Growth Metrics
Net Revenue Growth (1Y)	24.85%	16.29%	8.63%	6.24%	10.59%	13.83%	8.40%	1.19%	-10.04%	-12.05%	-7.35%
Net Income Growth (1Y)	-270.37%	-146.87%	-152.19%	-144.92%	1,894.96%	23,263.77%	188.29%	-1.81%	-93.79%	-99.56%	-31.99%
EPS Growth (1Y)	-264.37%	-145.42%	-150.94%	-143.80%	1,857.71%	22,819.23%	185.72%	-2.96%	-93.86%	-99.57%	-33.01%
Valuation Metrics
P/E TTM	-24.58	-102.70	-72.78	-141.37	27.38	29.55	26.97	40.40	454.90	7,053.92	58.76
P/B TTM	2.62	2.77	2.64	2.57	1.66	1.78	1.92	1.71	1.54	2.01	1.65
P/S TTM	3.25	3.84	3.90	3.97	2.65	2.74	3.01	2.68	2.45	3.19	2.47
Market Cap	2.70B	2.98B	2.81B	2.70B	1.77B	1.83B	1.99B	1.72B	1.47B	1.87B	1.51B
Enterprise Value	2.52B	2.79B	2.68B	2.55B	1.62B	1.71B	1.92B	1.69B	1.42B	1.81B	1.41B
Calculated Values
Free Cash Flow TTM	18.79M	82.25M	45.99M	70.75M	185.87M	163.35M	171.23M	162.76M	90.41M	103.69M	93.09M
Net Debt	-181.40M	-186.32M	-129.90M	-152.82M	-144.71M	-115.85M	-69.33M	-31.67M	-52.09M	-63.40M	-94.99M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-18Sale

Owner: Bhatt, Padmanabh P.

Title: Sr. VP of IP, CSO

Shares: 7,250

Price/Share: $50.02

Value: $362,645.00

Shares Owned: 17,044

Relationship: Officer

Ownership: Direct

2026-03-13Sale

Owner: Khattar, Jack A.

Title: President, CEO

Shares: 35,000

Price/Share: $50.95

Value: $1,783,250.00

Shares Owned: 958,100

Relationship: Director,Officer

Ownership: Indirect

2026-03-12Sale

Owner: Hudson, Frederick M.

Title: -

Shares: 5,369

Price/Share: $50.61

Value: $271,725.09

Shares Owned: 60,413

Relationship: Director

Ownership: Direct

2026-03-10Sale

Owner: Horich, William Todd

Title: SVP, Commercial Operations

Shares: 4,439

Price/Share: $55.00

Value: $244,145.00

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-03-09Sale

Owner: Mottola, Frank

Title: SVP, Chief Tech. Ops. Officer

Shares: 1,623

Price/Share: $53.65

Value: $87,073.95

Shares Owned: 18,440

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-18	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	7,250	50.02	$362,645.00	17,044	4
2026-03-13	Khattar, Jack A.	Director,Officer	President, CEO	Indirect	Sale	35,000	50.95	$1,783,250.00	958,100	4
2026-03-12	Hudson, Frederick M.	Director	-	Direct	Sale	5,369	50.61	$271,725.09	60,413	4
2026-03-10	Horich, William Todd	Officer	SVP, Commercial Operations	Direct	Sale	4,439	55.00	$244,145.00	0	4
2026-03-09	Mottola, Frank	Officer	SVP, Chief Tech. Ops. Officer	Direct	Sale	1,623	53.65	$87,073.95	18,440	4
2026-03-06	Gemayel, Georges	Director	-	Direct	Sale	8,787	53.00	$465,711.00	27,277	4
2026-02-19	Sensenig, Bethany	Director	-	Direct	Sale	4,475	50.79	$227,285.25	0	4
2025-12-19	Mottola, Frank	Officer	SVP, Chief Tech. Ops. Officer	Direct	Sale	20,000	50.34	$1,006,800.00	15,496	4
2025-12-18	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	710	44.44	$31,552.40	14,508	4
2025-10-09	Newhall, Charles W Iii	Director	-	Direct	Sale	25,000	51.14	$1,278,500.00	104,644	4
2025-10-09	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	59,900	51.00	$3,054,900.00	1,206,578	4
2025-10-02	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	1,904	48.06	$91,506.24	1,161,233	4
2025-10-01	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	40,173	48.07	$1,931,116.11	1,160,870	4
2025-09-30	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	8,588	48.25	$414,371.00	1,147,258	4
2025-09-29	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	10,235	48.02	$491,484.70	1,144,336	4
2025-09-23	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	29,513	47.23	$1,393,898.99	1,140,883	4
2025-09-22	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	16,587	47.02	$779,920.74	1,122,456	4
2025-09-12	Mottola, Frank	Officer	SVP, Chief Tech. Ops. Officer	Direct	Sale	5,000	45.87	$229,350.00	15,496	4
2025-09-08	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	6,322	46.29	$292,645.38	1,111,983	4
2025-09-05	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	55,578	46.01	$2,557,143.78	1,110,231	4
2025-08-28	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	24,150	45.12	$1,089,648.00	1,092,633	4
2025-08-27	Newhall, Charles W Iii	Director	-	Direct	Sale	3,588	45.01	$161,495.88	129,644	4
2025-08-25	Newhall, Charles W Iii	Director	-	Direct	Sale	1,000	45.00	$45,000.00	133,232	4
2025-08-25	Mottola, Frank	Officer	SVP, Quality, GMP, Ops, IT	Direct	Sale	14,000	44.51	$623,140.00	15,496	4
2025-08-25	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	1,000	45.00	$45,000.00	1,071,459	4
2025-08-22	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	1,500	45.00	$67,500.00	1,070,848	4
2025-08-22	Newhall, Charles W Iii	Director	-	Direct	Sale	1,412	45.00	$63,540.00	134,232	4
2025-08-22	Dec, Timothy C	Officer	Senior Vice-President & CFO	Direct	Sale	11,780	44.49	$524,092.20	1,246	4
2025-08-14	Sensenig, Bethany	Director	-	Direct	Sale	5,369	42.25	$226,840.25	0	4
2025-08-14	Hudson, Frederick M.	Director	-	Direct	Sale	7,457	42.26	$315,132.82	46,307	4
2025-08-06	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	140,000	41.79	$5,850,600.00	1,030,183	4
2025-02-21	Rubin, Jonathan	Officer	SVP, Chief Medical Officer	Direct	Sale	927	39.15	$36,292.05	7,853	4
2025-02-04	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	9,477	39.70	$376,236.90	10,149	4
2025-01-28	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	700	39.62	$27,734.00	10,149	4
2024-12-03	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	21,495	36.68	$788,436.60	9,679	4
2024-11-11	Newhall, Charles W Iii	Director	-	Direct	Sale	10,700	36.24	$387,768.00	130,275	4
2024-11-08	Hudson, Frederick M.	Director	-	Direct	Sale	8,722	36.28	$316,434.16	28,395	4
2024-11-08	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	125,000	36.29	$4,536,250.00	926,172	4
2024-11-08	Gemayel, Georges	Director	-	Direct	Sale	10,787	36.30	$391,568.10	13,315	4
2024-11-07	Gemayel, Georges	Director	-	Direct	Sale	14,213	36.62	$520,480.06	13,315	4
2024-11-07	Khattar, Jack A.	Director,Officer	President, CEO	Direct	Sale	125,000	36.68	$4,585,000.00	926,172	4
2024-11-07	Mottola, Frank	Officer	SVP, Quality, GMP, Ops, IT	Direct	Sale	15,000	36.98	$554,700.00	8,200	4
2024-09-13	Gemayel, Georges	Director	-	Direct	Sale	13,886	31.33	$435,048.38	13,315	4
2024-03-21	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	14,491	35.31	$511,677.21	8,570	4
2024-03-20	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	400	35.31	$14,124.00	8,570	4
2024-03-19	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	12,364	35.31	$436,572.84	8,570	4
2024-03-13	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	62,366	33.79	$2,107,347.14	8,570	4
2024-03-12	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	3,884	32.99	$128,133.16	8,570	4
2024-02-26	Bhatt, Padmanabh P.	Officer	Sr. VP of IP, CSO	Direct	Sale	5,000	30.21	$151,050.00	8,570	4
2024-01-10	Martin, Tami Tillotson	Officer	Sr. V.P., Regulatory Affairs	Direct	Sale	8,000	27.91	$223,280.00	85,664	4
2023-11-16	Newhall, Charles W Iii	Director	-	Direct	Sale	2,500	28.01	$70,025.00	117,089	4
2023-11-15	Hudson, Frederick M.	Director	-	Direct	Sale	9,093	28.50	$259,150.50	33,231	4
2023-11-14	Mottola, Frank	Officer	SVP, Quality, GMP, Ops, IT	Direct	Sale	1,110	28.13	$31,224.30	5,681	4
2023-08-30	Martin, Tami Tillotson	Officer	Sr. V.P., Regulatory Affairs	Direct	Sale	8,100	32.00	$259,200.00	85,249	4
2023-08-25	Martin, Tami Tillotson	Officer	Sr. V.P., Regulatory Affairs	Direct	Sale	5,135	31.59	$162,214.65	85,249	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

96.69%

Inst. Shares: 55,739,419

Shares Outstanding: 57,647,548

2025-12-31

96.97%

Inst. Shares: 54,740,019

Shares Outstanding: 56,451,136

2025-09-30

97.92%

Inst. Shares: 55,375,576

Shares Outstanding: 56,552,741

2025-06-30

101.48%

Inst. Shares: 56,855,011

Shares Outstanding: 56,024,771

2025-03-31

98.49%

Inst. Shares: 55,021,681

Shares Outstanding: 55,864,692

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	55,739,419	57,647,548	96.69%
2025-12-31	54,740,019	56,451,136	96.97%
2025-09-30	55,375,576	56,552,741	97.92%
2025-06-30	56,855,011	56,024,771	101.48%
2025-03-31	55,021,681	55,864,692	98.49%
2024-12-31	55,965,362	55,100,063	101.57%
2024-09-30	55,883,600	55,149,760	101.33%
2024-06-30	54,535,371	54,978,781	99.19%
2024-03-31	50,721,102	54,801,748	92.55%
2023-12-31	50,473,955	54,801,748	92.10%
2023-09-30	50,539,268	54,608,963	92.55%
2023-06-30	51,008,479	54,502,993	93.59%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — SEC Financial Statements & Analysis

SUPERNUS PHARMACEUTICALS, INC. (SUPN) is a pharmaceutical preparations company, incorporated in DE. SUPERNUS PHARMACEUTICALS, INC. trades on Nasdaq as: SUPN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SUPERNUS PHARMACEUTICALS, INC. reported a 24.85% year-over-year revenue growth, a Gross Profit Margin of 88.07% (TTM), a Debt-to-Equity ratio of 0.38x, a Price-to-Sales (P/S) ratio of 3.25x (TTM), a Price-to-Book (P/B) ratio of 2.62x (TTM), at a market cap of $2.70B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 24.85%
Gross Profit Margin TTM: 88.07%
Debt To Equity: 0.38x
P/S TTM: 3.25x
P/B TTM: 2.62x
Market Cap: $2.70B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SUPERNUS PHARMACEUTICALS, INC. in?

SUPERNUS PHARMACEUTICALS, INC. (SUPN) operates in the Pharmaceutical Preparations industry.

What is SUPN's market cap?

SUPERNUS PHARMACEUTICALS, INC. (SUPN) has a market capitalization of $2.70B as of 2026-06-30.

What exchange does SUPN trade on?

SUPERNUS PHARMACEUTICALS, INC. (SUPN) trades on the Nasdaq.

Where is SUPERNUS PHARMACEUTICALS, INC. incorporated?

SUPERNUS PHARMACEUTICALS, INC. is incorporated in DE.